Skip to main content
S. 2609 117th Congress Senate

Facilitating Innovative Nuclear Diagnostics Act of 2021

Official title: A bill to amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceut… Show full official titleShow less

Official title: A bill to amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.

Introduced: August 4, 2021 Introduced by: Marsha Blackburn Republican · Tennessee See on congress.gov
Health Health care costs and insuranceMedical tests and diagnostic methodsMedicareRadiation
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 4, 2021
Read twice and referred to the Committee on Finance.
Aug 4, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action August 4, 2021

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Facilitating Innovative Nuclear Diagnostics Act of 2021

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 8

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • FARRAGUT PARTNERS LLP
    for LANTHEUS MEDICAL IMAGING, INC. · Massachusetts · 3rd Quarter 2026 (July 1 - Sep 30)
  • FARRAGUT PARTNERS LLP
    for LANTHEUS MEDICAL IMAGING, INC. · Massachusetts · 2nd Quarter 2026 (Apr 1 - June 30)
  • FARRAGUT PARTNERS LLP
    for LANTHEUS MEDICAL IMAGING, INC. · Massachusetts · 1st Quarter 2026 (Jan 1 - Mar 31)
  • FARRAGUT PARTNERS LLP
    for LANTHEUS MEDICAL IMAGING, INC. · Massachusetts · 4th Quarter 2025 (Oct 1 - Dec 31)
  • FARRAGUT PARTNERS LLP
    for LANTHEUS MEDICAL IMAGING, INC. · Massachusetts · 3rd Quarter 2025 (July 1 - Sep 30)
  • FARRAGUT PARTNERS LLP
    for LANTHEUS MEDICAL IMAGING, INC. · Massachusetts · 2nd Quarter 2025 (Apr 1 - June 30)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 8 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2609: Facilitating Innovative Nuclear Diagnostics Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2609/
MLA
"S. 2609: Facilitating Innovative Nuclear Diagnostics Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2609/.
Bluebook (legal)
S. 2609, 117th Cong. (2026), https://openamerica.io/bill/117-S-2609/.
Markdown link
[S. 2609: Facilitating Innovative Nuclear Diagnostics Act of 2021](https://openamerica.io/bill/117-S-2609/)
Report a problem